Annual Gross Profit
N/A
31 December 2023
Summary:
Celldex Therapeutics annual gross profit is not available.CLDX Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Gross Profit
N/A
01 September 2024
Summary:
Celldex Therapeutics quarterly gross profit is not available.CLDX Quarterly Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Gross Profit
N/A
01 September 2024
Summary:
Celldex Therapeutics TTM gross profit is not available.CLDX TTM Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CLDX Gross Profit Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | - | - | - |
3 y3 years | - | - | - |
5 y5 years | - | - | - |
CLDX Gross Profit High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | ||||||
5 y | 5 years | ||||||
alltime | all time |
Celldex Therapeutics Gross Profit History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2013 | $1.78 M(+316.2%) | $620.00 K(-36.7%) | $1.78 M(+41.8%) |
Sept 2013 | - | $980.00 K(+910.3%) | $1.25 M(+229.7%) |
June 2013 | - | $97.00 K(+21.3%) | $380.00 K(-9.3%) |
Mar 2013 | - | $80.00 K(-16.7%) | $419.00 K(-2.1%) |
Dec 2012 | $427.00 K(+192.5%) | $96.00 K(-10.3%) | $428.00 K(-106.7%) |
Sept 2012 | - | $107.00 K(-21.3%) | -$6.35 M(+55.1%) |
June 2012 | - | $136.00 K(+52.8%) | -$4.10 M(-3.0%) |
Mar 2012 | - | $89.00 K(-101.3%) | -$4.22 M(-1.7%) |
Dec 2011 | $146.00 K(-99.6%) | -$6.68 M(-382.9%) | -$4.30 M(-112.9%) |
Sept 2011 | - | $2.36 M(>+9900.0%) | $33.31 M(+3.7%) |
June 2011 | - | $11.00 K(-21.4%) | $32.14 M(-3.6%) |
Mar 2011 | - | $14.00 K(-100.0%) | $33.34 M(-4.0%) |
Dec 2010 | $34.72 M(+411.8%) | $30.92 M(+2498.4%) | $34.72 M(+498.6%) |
Sept 2010 | - | $1.19 M(-2.4%) | $5.80 M(-11.7%) |
June 2010 | - | $1.22 M(-12.0%) | $6.57 M(-1.5%) |
Mar 2010 | - | $1.39 M(-30.9%) | $6.67 M(-1.7%) |
Dec 2009 | $6.78 M(+81.1%) | $2.00 M(+2.4%) | $6.78 M(+42.0%) |
Sept 2009 | - | $1.96 M(+48.8%) | $4.78 M(+69.5%) |
June 2009 | - | $1.32 M(-12.4%) | $2.82 M(+87.6%) |
Mar 2009 | - | $1.50 M(-333.9%) | $1.50 M(-333.9%) |
Dec 2008 | $3.75 M(-43.8%) | - | - |
Mar 2006 | - | -$642.20 K(-79.0%) | -$642.20 K(-79.0%) |
Mar 2005 | - | -$3.06 M(-477.4%) | -$3.06 M(-145.9%) |
Dec 2002 | $6.66 M(+101.4%) | $810.80 K(-82.2%) | $6.66 M(-1.7%) |
Sept 2002 | - | $4.55 M(+627.1%) | $6.78 M(+130.1%) |
June 2002 | - | $625.80 K(-7.6%) | $2.95 M(-6.1%) |
Mar 2002 | - | $677.20 K(-26.8%) | $3.14 M(-18.6%) |
Dec 2001 | $3.31 M(+127.8%) | $925.60 K(+29.1%) | $3.85 M(+13.0%) |
Sept 2001 | - | $717.10 K(-12.3%) | $3.41 M(+13.4%) |
June 2001 | - | $817.60 K(-41.3%) | $3.01 M(+20.0%) |
Mar 2001 | - | $1.39 M(+188.5%) | $2.51 M(+72.6%) |
Dec 2000 | $1.45 M(-33.9%) | $483.00 K(+53.3%) | $1.45 M(+36.3%) |
Sept 2000 | - | $315.10 K(-0.1%) | $1.07 M(-21.1%) |
June 2000 | - | $315.30 K(-7.0%) | $1.35 M(-31.9%) |
Mar 2000 | - | $339.10 K(+252.1%) | $1.98 M(-7.5%) |
Dec 1999 | $2.20 M(-13.9%) | $96.30 K(-84.0%) | $2.14 M(-30.8%) |
Sept 1999 | - | $600.00 K(-36.7%) | $3.10 M(0.0%) |
June 1999 | - | $947.90 K(+89.6%) | $3.10 M(+21.5%) |
Mar 1999 | - | $500.00 K(-52.4%) | $2.55 M(0.0%) |
Dec 1998 | $2.55 M | $1.05 M(+75.1%) | $2.55 M(+34.8%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 1998 | - | $600.00 K(+50.0%) | $1.89 M(+26.8%) |
June 1998 | - | $400.00 K(-20.0%) | $1.49 M(-21.1%) |
Mar 1998 | - | $500.00 K(+27.5%) | $1.89 M(+18.8%) |
Dec 1997 | $1.49 M(+24.3%) | $392.10 K(+96.0%) | $1.59 M(+32.7%) |
Sept 1997 | - | $200.00 K(-75.0%) | $1.20 M(-7.7%) |
June 1997 | - | $800.00 K(+300.0%) | $1.30 M(+62.5%) |
Mar 1997 | - | $200.00 K(-33.3%) | $800.00 K(-52.9%) |
Dec 1996 | $1.20 M(-57.1%) | - | - |
Sept 1996 | - | $300.00 K(0.0%) | $1.70 M(-5.6%) |
June 1996 | - | $300.00 K(-25.0%) | $1.80 M(-21.7%) |
Mar 1996 | - | $400.00 K(-42.9%) | $2.30 M(-17.9%) |
Dec 1995 | $2.80 M(-51.7%) | $700.00 K(+75.0%) | $2.80 M(0.0%) |
Sept 1995 | - | $400.00 K(-50.0%) | $2.80 M(-22.2%) |
June 1995 | - | $800.00 K(-11.1%) | $3.60 M(-21.7%) |
Mar 1995 | - | $900.00 K(+28.6%) | $4.60 M(-19.3%) |
Dec 1994 | $5.80 M(-22.7%) | $700.00 K(-41.7%) | $5.70 M(-14.9%) |
Sept 1994 | - | $1.20 M(-33.3%) | $6.70 M(-8.2%) |
June 1994 | - | $1.80 M(-10.0%) | $7.30 M(-6.4%) |
Mar 1994 | - | $2.00 M(+17.6%) | $7.80 M(+1.3%) |
Dec 1993 | $7.50 M(+25.0%) | $1.70 M(-5.6%) | $7.70 M(+28.3%) |
Sept 1993 | - | $1.80 M(-21.7%) | $6.00 M(-14.3%) |
June 1993 | - | $2.30 M(+21.1%) | $7.00 M(+4.5%) |
Mar 1993 | - | $1.90 M(-32.1%) | $6.70 M(-31.6%) |
Dec 1992 | $6.00 M(-23.1%) | - | - |
Oct 1992 | - | $2.80 M(+40.0%) | $9.80 M(+16.7%) |
July 1992 | - | $2.00 M(-9.1%) | $8.40 M(+7.7%) |
Apr 1992 | - | $2.20 M(-21.4%) | $7.80 M(+1.3%) |
Apr 1992 | $7.80 M(-14.3%) | - | - |
Jan 1992 | - | $2.80 M(+100.0%) | $7.70 M(+6.9%) |
Oct 1991 | - | $1.40 M(0.0%) | $7.20 M(-12.2%) |
July 1991 | - | $1.40 M(-33.3%) | $8.20 M(-8.9%) |
Apr 1991 | $9.10 M(-9.9%) | $2.10 M(-8.7%) | $9.00 M(-10.9%) |
Jan 1991 | - | $2.30 M(-4.2%) | $10.10 M(-8.2%) |
Oct 1990 | - | $2.40 M(+9.1%) | $11.00 M(+27.9%) |
July 1990 | - | $2.20 M(-31.3%) | $8.60 M(+34.4%) |
Apr 1990 | $10.10 M(+44.3%) | $3.20 M(0.0%) | $6.40 M(+100.0%) |
Jan 1990 | - | $3.20 M | $3.20 M |
Apr 1989 | $7.00 M(+62.8%) | - | - |
Apr 1988 | $4.30 M(+87.0%) | - | - |
Apr 1987 | $2.30 M | - | - |
FAQ
- What is the all time high annual gross profit for Celldex Therapeutics?
- What is the all time high quarterly gross profit for Celldex Therapeutics?
- What is the all time high TTM gross profit for Celldex Therapeutics?
What is the all time high annual gross profit for Celldex Therapeutics?
Celldex Therapeutics all-time high annual gross profit is $34.72 M
What is the all time high quarterly gross profit for Celldex Therapeutics?
Celldex Therapeutics all-time high quarterly gross profit is $30.92 M
What is the all time high TTM gross profit for Celldex Therapeutics?
Celldex Therapeutics all-time high TTM gross profit is $34.72 M